|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006684,
umls-concept:C0006826,
umls-concept:C0010068,
umls-concept:C0021308,
umls-concept:C0030705,
umls-concept:C0035168,
umls-concept:C0035647,
umls-concept:C0199176,
umls-concept:C1257890,
umls-concept:C1415761,
umls-concept:C2603343
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-4-9
|
|
pubmed:abstractText |
This analysis sought to estimate the risk ratio for cancer incidence and cancer-related mortality associated with the use of calcium channel blocking agents (CCBs) in a large group of patients with chronic coronary heart disease (CHD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
804-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9525550-Aged,
pubmed-meshheading:9525550-Calcium Channel Blockers,
pubmed-meshheading:9525550-Cause of Death,
pubmed-meshheading:9525550-Confidence Intervals,
pubmed-meshheading:9525550-Coronary Disease,
pubmed-meshheading:9525550-Diltiazem,
pubmed-meshheading:9525550-Female,
pubmed-meshheading:9525550-Humans,
pubmed-meshheading:9525550-Male,
pubmed-meshheading:9525550-Middle Aged,
pubmed-meshheading:9525550-Neoplasms,
pubmed-meshheading:9525550-Nifedipine,
pubmed-meshheading:9525550-Odds Ratio,
pubmed-meshheading:9525550-Risk Factors,
pubmed-meshheading:9525550-Verapamil
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
|
|
pubmed:affiliation |
Department of Cardiology, Tel Aviv Medical Center, Israel. braun@netvision.net.il
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
